October 16, 2020
COVID-19 articles focus on risks for mental health and substance use disorders
Two recently published articles use large health datasets to examine the intersection of the COVID-19 pandemic and mental and substance use disorders.
Wang Q, Xu R, Volkow ND (2020). Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry (Impact factor: 40.59).First published: 07 October 2020. https://doi.org/10.1002/wps.2080
Wang Q, Kaelber D, Xu R, Volkow ND (2020). COVID-19 Risk and Outcomes in patients with substance use disorders: Analyses from electronic health records in the United States. Molecular Psychiatry (2020) DOI https://doi.org/10.1038/s41380-020-00880-7.
June 23, 2020
The Northeast Node is now hiring a Research Assistant for a new study investigating a prevention strategy for opioid use disorder in primary care settings. This position is based at two primary care practices in Manchester and Bedford, New Hampshire. Once COVID-19 restrictions in the State of NH are lifted, this position will be based directly in these two clinics.
The right candidate is someone who is passionate about health services and helping people with opioid use disorder. Prior research experience is a bonus but we are willing to train the right person.
For more information about this posting, or to apply, please visit https://searchjobs.dartmouth.edu/postings/54706
Dartmouth College is an equal opportunity/affirmative action employer with a strong commitment to diversity and inclusion. We prohibit discrimination on the basis of race, color, religion, sex, age, national origin, sexual orientation, gender identity or expression, disability, veteran status, marital status, or any other legally protected status. Applications by members of all underrepresented groups are encouraged.
May 7, 2020
NIDA compiling resources for COVID-19
The COVID-19 pandemic presents unique challenges for people with substance use disorders (SUDs) and people in recovery. To address the urgency of this rapidly evolving situation, The National Institute on Drug Abuse (NIDA) has compiled a list of COVID-19 resource pages from federal agencies.
Visit NIDA’s website for more information.
September 30, 2019
NIH awards nearly $1 billion in research grants to battle addiction, chronic pain
Article Excerpt: The National Institutes of Health awarded nearly $1 billion on Thursday to battle addiction and chronic pain, the largest financial commitment to one program ever by the government’s premier biomedical research center…Included in the grants, (NIH Director Francis S. Collins) said, is one to Dartmouth College to study ways of initiating drug treatment in hospital emergency rooms rather than days later at treatment centers. Another will help a small company test a device worn on the wrist to detect biomarkers for stress and cravings in an effort to determine how long people need to continue treatment. A third will look at best practices for the care of hundreds of thousands of infants who have been born to mothers who used opioids during pregnancy.
June 27, 2019
Five Geisel Faculty Win National Healthcare Delivery Award
Bonny Whalen, MD, Steve Chapman, MD, Alison Holmes, MD, MPH, Julia Frew, MD (MED ’05), and Daisy Goodman, DNP, MPH (TDI ’14), received the Academic Pediatric Association’s (APA) Health Care Delivery award for their work with mothers and newborns with opioid dependence. The Center for Addiction Recovery in Pregnancy and Parenting (CARRP) is a multidisciplinary network of experienced clinicians and researchers working together to support recovery from addiction for women who are pregnant and parenting, and to promote healthy growth and development in their children.
June 25, 2019
There are openings for a Project Manager, Research Assistant, and Research Coordinator at the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN).
June 7, 2019
Welcoming Applicants for NIDA T-32 Science of Co-Occurring Disorders Postdoctoral Training Program
The NIDA T-32 Science of Co-Occurring Disorders Postdoctoral Training Program, led by Northeast Node faculty affiliate Alan Budney, PhD at Dartmouth College, is welcoming post-doctoral fellow applicants. This is a unique transdisciplinary/translational research program focused on co-occurring substance use and other mental or physical disorders offered through the Geisel School of Medicine at Dartmouth. During the typical 2-3 year-long appointments, postdoctoral fellows will be provided with research opportunities in intervention research under the mentorship of faculty that are experts in their fields and leading diverse projects funded by NIH and other federal institutes. To be eligible, applicants must have completed their training in psychology, or a related discipline and be U.S. citizens or permanent residents. Trainees are selected on the basis of scholastic record and commitment to a career in research related to addiction and mental health. Benefits include a stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards. To apply, applicants should forward their curriculum vitae, statement of research interests, and 3 letters of reference to Brian Goodness. Contact Dr. Budney, or Dr. Stanger for more information.
April 30, 2019
Announcing CTN-0103, “Expanding Clinical Research Training on Implementing the Evidence-based Hub and Spoke Model of Medication-Assisted Treatment for Opioid Use Disorder”
The Northeast Node is pleased to announce CTN-0103, entitled “Expanding Clinical Research Training on Implementing the Evidence-based Hub and Spoke Model of Medication-Assisted Treatment for Opioid Use Disorder”. The Vermont Hub and Spoke Model (VT HSM) of substance use disorder care allows providers to initiate medication treatment for persons with opioid use disorder with assistance from local opioid treatment programs (Hubs) and then support ongoing care of patients through office-based treatment (Spokes) (with flexible movement back into Hubs for patients in need of additional stabilization). The Node will collaborate with its partner, the New Hampshire (NH) Citizens Health Initiative, that helps lead the Northern New England (NNE) Project ECHO (Extension for Community Healthcare Outcomes) Network across ME, NH, and VT. The NNE ECHO is an expansive collaborative designed to implement a regional network of telehealth services for sharing of knowledge from multidisciplinary expert mentors and teams across a virtual network using the Project ECHO model. This model uses web-supported case-based learning to provide direct education and support to clinicians and communities addressing the opioid epidemic to improve access, care delivery, outcomes and health.
April 8, 2019
Our team is hiring for a Research Assistant
There is an opening for a Research Assistant position for the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN). We are looking for someone to provide support and assistance to the Principal Investigator, Director of Operations, and Research Project Managers on projects aimed at developing, evaluating, and disseminating new prevention and treatment options for substance use disorders in community-based medical settings in Maine, New Hampshire, and Vermont. In addition to helping with study procedures, this position will aid in the dissemination/communications of Northeast Node activities to a broad array of stakeholders; work collaboratively with local partners, other CTN nodes across the US, and the National Institute on Drug Abuse (NIDA); assist with social media and website management; and utilize knowledge of the Node partners’ research interests to assist with leveraging CTN-funded studies to the rural areas represented by the Northeast Node.
More details on this position and how to apply here: https://searchjobs.dartmouth.edu/postings/49952
March 28, 2019
Northeast Node joins New England Consortium and Health Systems Node on CTN-0092, “Opioid Use Disorder (OUD) Phenotyping Feasibility for Clinical Trials.”
The Northeast Node (PI Dr. Lisa Marsch) is very pleased to join the New England Consortium (Lead Node, PI Dr. Kathleen Carroll) and the Health Systems Node (PI Dr. Cynthia Campbell) on CTN-0092, “Opioid Use Disorder (OUD) Phenotyping Feasibility for Clinical Trials.”